Ocrelizumab in multiple sclerosis: markers and mechanisms.
Institute of Clinical Neuroimmunology, University Hospitals and Biomedical Center, Ludwig Maximilians University, Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany. Electronic address: reinhard.hohlfeld@med.uni-muenchen.de.
Reinhard
R
Hohlfeld
Institute of Clinical Neuroimmunology, University Hospitals and Biomedical Center, Ludwig Maximilians University, Munich, Germany; Munich Cluster of Systems Neurology (SyNergy), Munich, Germany.
Edgar
E
Meinl